Purdue Pharma reaches settlement with feds: Baton Rouge case still in the works

    Purdue Pharma, the maker of OxyContin, has reached a $8.34 billion settlement with the U.S. Justice Department and agreed to plead guilty to three felonies over its role in the nation’s opioid crisi…

    Already an INSIDER? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.